ACTIVE_NOT_RECRUITING

Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment

Talk to us

Conditions

Type 2 DiabetesMild Cognitive ImpairmentContinuous Glucose Monitoring (CGM)

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Eligible older adults with Type 2 Diabetes-Mild Cognitive Impairment (T2D-MCI) will be provided a Continuous Glucose Monitoring (CGM) device and asked to share CGM data with their care partners for daily decision-making for diabetes self-management. After 2 weeks, individual interviews will be conducted in 20 participants (10 dyads). Older adults with T2D-MCI (n=10) and their care partners (n=10) will be interviewed separately to identify key features of the Care Partner-Assisted Intervention through linking continuous glucose monitoring and Mobile Health (CP-CGMH) app.

Official Title

CP-CGMH: Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment

Quick Facts

Study Start:2023-04-19
Study Completion:2027-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05601583

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. be ≥ 65 years old;
  2. 2. have had a diagnosis of T2D for at least one year;
  3. 3. have MCI, defined as score 19-25 on the Montreal Cognitive Assessment (MoCA);60,61
  4. 4. have a care partner (e.g., spouse or adult children);
  5. 5. be willing to use CGM;
  6. 6. be fluent in English.
  7. 1. ≥ 18 years old;
  8. 2. living with older adults with T2D-MCI;
  9. 3. willing to be involved in patients' daily care;
  10. 4. fluent in English.
  1. 1. Refuse or are unable to provide informed consent;
  2. 2. Have serious physical illness (e.g., end-stage renal disease);
  3. 3. Presence of mental illness (e.g., schizophrenia or bipolar disorder) that would preclude participation.
  4. 1. Refuse or are unable to provide informed consent;
  5. 2. Have MCI.

Contacts and Locations

Principal Investigator

Yaguang Zheng, PhD, RN
PRINCIPAL_INVESTIGATOR
Rory Meyers College of Nursing

Study Locations (Sites)

Bellevue Hospital
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Yaguang Zheng, PhD, RN, PRINCIPAL_INVESTIGATOR, Rory Meyers College of Nursing

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-19
Study Completion Date2027-08-31

Study Record Updates

Study Start Date2023-04-19
Study Completion Date2027-08-31

Terms related to this study

Keywords Provided by Researchers

  • Continuous Glucose Monitoring (CGM)

Additional Relevant MeSH Terms

  • Type 2 Diabetes
  • Mild Cognitive Impairment